REGiMMUNE Signed Underwriting Contract with HuaNan Securities
Taipei, July 6, 2023 – REGiMMUNE Limited (REGiMMUNE), a biotech [...]
Taipei, July 6, 2023 – REGiMMUNE Limited (REGiMMUNE), a biotech [...]
Taipei, March 29, 2023 – REGiMMUNE Limited (REGiMMUNE), a biotech [...]
RGI-2001 was well tolerated and associated with a meaningful reduction [...]
TAIPEI, November 3, 2022 – REGiMMUNE Limited, a clinical-stage biopharmaceutical [...]
Taipei, 16 May 2022 – REGiMMUNE Limited, a biopharmaceutical company [...]
REGiMMUNE Corporation has presented clinical data on RGI-2001 Intravenous [...]